Intas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection Dr. Divya Colin12 March 2025 5:45 PM ISTNew Delhi: Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva Ruchika Sharma22 Dec 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained marketing...
Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment Ruchika Sharma14 Dec 2024 12:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With Advanced Epithelial Ovarian Cancer: Merck Ruchika Sharma11 Dec 2024 5:54 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA...
Zydus Lifesciences gets Mexican regulatory authority marketing nod for cancer drug Bhava Ruchika Sharma22 July 2024 2:59 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against...
Biocon arm receives EMA approval to manufacture biosimilar Bevacizumab at Bengaluru facility Ruchika Sharma24 Jun 2024 12:15 PM ISTBengaluru: Biocon Biologics Ltd, a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the...
Dr Reddys Labs unveils Versavo in UK for several types of cancers Ruchika Sharma20 March 2024 2:30 PM ISTHyderabad: Dr Reddy's Laboratories Ltd., a global pharmaceutical company, has announced the launch of Versavo (bevacizumab) in the United Kingdom...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
Targeted Drug Therapy to help survival in Liver Cancer Niveditha Subramani29 Jan 2024 7:38 PM ISTAs researchers learn more about the changes in cells that cause cancer, they have been able to develop newer drugs that specifically target these...
Medical Bulletin 11/January/2024 Anshika Mishra11 Jan 2024 3:00 PM ISTHere are the top medical news of the day:Combining anti-tumor drugs with chemo may improve rare children’s cancer outcomesChildren who develop...
Combining anti tumor drugs with chemo may improve rare children's cancer outcomes Anshika Mishra11 Jan 2024 9:00 AM ISTChildren who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumour drugs as well...
Single intravitreal dose of bevacizumab during trabeculectomy with mitomycin-C improved surgical success Niveditha Subramani13 Aug 2023 8:00 PM ISTTrabeculectomy is a most popular surgery performed in glaucoma patients. Before the development of the trabeculectomy, the available surgical methods...
